Blackstone (NYSE:BX) has started the process of selling its controlling stake in South Korean pharmaceutical wholesaler Geo-Young in a deal estimated to be worth up to $1.4B, according to a media report Wednesday.
The private equity firm, which in 2019 acquired a 71% stake in Geo-Young at an enterprise value of 1.1T won (US$845.8M), recently asked investment banks to choose underwriters for the proposed transaction, The Korea Economic Daily reported, citing people with knowledge of the matter.
The article pointed out that Geo-Young is South Korea’s largest medicine wholesaler by revenue, controlling some 80% of the domestic medicine and medical device distribution market.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Blackstone (BX) controls 99.17% of Geo-Young in a consortium with the latter’s co-founders Cho Hae-sun and Lee Hee-koo. Cho has a 22% stake, while Lee holds a 7% stake, the article said, though it remains to be seen whether they will sell their combined stake.
Source: Seeking Alpha
Can’t stop reading? Read more
Rent the Runway cedes control to PE investors in $260m debt restructuring
Rent the Runway cedes control to PE investors in $260m debt restructuring Rent the Runway has...
Astorg expands Mid-Cap strategy with ATTIKON acquisition in Germany
Astorg expands Mid-Cap strategy with ATTIKON acquisition in Germany Astorg has agreed to acquire a...
Global giant Apollo to double India exposure amid $1tn infrastructure drive
Global giant Apollo to double India exposure amid $1tn infrastructure drive Apollo Global...